v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Brixmor Operating Partnership LP
Common Stock
Additional Paid-in Capital
Partnership Common Units
Brixmor Operating Partnership LP
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Brixmor Operating Partnership LP
Distributions in Excess of Net Income
Non-controlling Interests
Non-controlling Interests
Brixmor Operating Partnership LP
Beginning balance (in shares) at Dec. 31, 2023     300,596              
Beginning balance at Dec. 31, 2023 $ 2,850,301 $ 2,850,280 $ 3,006 $ 3,310,590 $ 2,852,980 $ (2,700) $ (2,700) $ (460,595) $ 0 $ 0
Increase (Decrease) in Equity [Roll Forward]                    
Distributions to partners (83,277)             (83,277)    
Distributions to partners   (83,851)     (83,851)          
Equity based compensation expense 3,781 3,781   3,781 3,781          
Other comprehensive income (loss) 12,226 12,226       12,226 12,226      
Issuance of common stock, net of issuance costs (in shares)     703              
Issuance of common stock, net of issuance costs 0   $ 7 (7)            
Repurchases of common shares in conjunction with equity award plans (12,962) (12,962)   (12,962) (12,962)          
Net income 88,905 88,905     88,905     88,905    
Ending balance (in shares) at Mar. 31, 2024     301,299              
Ending balance at Mar. 31, 2024 2,858,974 2,858,379 $ 3,013 3,301,402 2,848,853 9,526 9,526 (454,967) 0 0
Beginning balance (in shares) at Dec. 31, 2023     300,596              
Beginning balance at Dec. 31, 2023 2,850,301 2,850,280 $ 3,006 3,310,590 2,852,980 (2,700) (2,700) (460,595) 0 0
Increase (Decrease) in Equity [Roll Forward]                    
Other comprehensive income (loss) 15,077 15,077                
Net income 159,030 159,030                
Ending balance (in shares) at Jun. 30, 2024     301,345              
Ending balance at Jun. 30, 2024 2,855,186 2,854,591 $ 3,013 3,307,357 2,842,214 12,377 12,377 (467,561) 0 0
Beginning balance (in shares) at Mar. 31, 2024     301,299              
Beginning balance at Mar. 31, 2024 2,858,974 2,858,379 $ 3,013 3,301,402 2,848,853 9,526 9,526 (454,967) 0 0
Increase (Decrease) in Equity [Roll Forward]                    
Distributions to partners (82,719)             (82,719)    
Distributions to partners   (82,719)     (82,719)          
Equity based compensation expense 5,955 5,955   5,955 5,955          
Other comprehensive income (loss) 2,851 2,851       2,851 2,851      
Issuance of common stock, net of issuance costs (in shares)     46              
Issuance of common stock, net of issuance costs 0   $ 0 0            
Net income 70,125 70,125     70,125     70,125    
Ending balance (in shares) at Jun. 30, 2024     301,345              
Ending balance at Jun. 30, 2024 2,855,186 2,854,591 $ 3,013 3,307,357 2,842,214 12,377 12,377 (467,561) 0 0
Beginning balance (in shares) at Dec. 31, 2024     305,492              
Beginning balance at Dec. 31, 2024 2,983,922 2,983,262 $ 3,055 3,431,043 2,974,800 8,218 8,218 (458,638) 244 244
Increase (Decrease) in Equity [Roll Forward]                    
Distributions to partners (88,492)             (88,492)    
Distributions to partners   (88,916)     (88,916)          
Equity based compensation expense 4,650 4,650   4,650 4,650          
Other comprehensive income (loss) (4,143) (4,143)       (4,143) (4,143)      
Issuance of common stock, net of issuance costs (in shares)     568              
Issuance of common stock, net of issuance costs 0   $ 6 (6)            
Repurchases of common shares in conjunction with equity award plans (11,645) (11,645)   (11,645) (11,645)          
Net income 69,737 69,737     69,729     69,729 8 8
Ending balance (in shares) at Mar. 31, 2025     306,060              
Ending balance at Mar. 31, 2025 2,954,029 2,952,945 $ 3,061 3,424,042 2,948,618 4,075 4,075 (477,401) 252 252
Beginning balance (in shares) at Dec. 31, 2024     305,492              
Beginning balance at Dec. 31, 2024 2,983,922 2,983,262 $ 3,055 3,431,043 2,974,800 8,218 8,218 (458,638) 244 244
Increase (Decrease) in Equity [Roll Forward]                    
Other comprehensive income (loss) (6,134) (6,134)                
Net income 154,883 154,883                
Ending balance (in shares) at Jun. 30, 2025     306,100              
Ending balance at Jun. 30, 2025 2,953,164 2,952,080 $ 3,061 3,428,611 2,949,737 2,084 2,084 (480,851) 259 259
Beginning balance (in shares) at Mar. 31, 2025     306,060              
Beginning balance at Mar. 31, 2025 2,954,029 2,952,945 $ 3,061 3,424,042 2,948,618 4,075 4,075 (477,401) 252 252
Increase (Decrease) in Equity [Roll Forward]                    
Distributions to partners (88,589)             (88,589)    
Distributions to partners   (88,589)     (88,589)          
Equity based compensation expense 5,135 5,135   5,135 5,135          
Other comprehensive income (loss) (1,991) (1,991)       (1,991) (1,991)      
Issuance of common stock, net of issuance costs (in shares)     40              
Issuance of common stock, net of issuance costs 0                  
Repurchases of common shares in conjunction with equity award plans (566) (566)   (566) (566)          
Net income 85,146 85,146     85,139     85,139 7 7
Ending balance (in shares) at Jun. 30, 2025     306,100              
Ending balance at Jun. 30, 2025 $ 2,953,164 $ 2,952,080 $ 3,061 $ 3,428,611 $ 2,949,737 $ 2,084 $ 2,084 $ (480,851) $ 259 $ 259